Across TCGA pan-cancer cohorts, ZNF733P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZNF733P data layer compared with 12 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ZNF733P Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated ZNF733P expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
UCEC, COAD, and SKCM are the cancer types where ZNF733P Mutation most reproducibly stratifies survival.